Terns Pharmaceuticals, Inc.

NASDAQ:TERN

4.66 (USD) • At close February 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operating Activities:
Net Income -21.945-22.736-22.373-21.019-29.767-17.896-21.528-15.822-16.82-13.93-13.773-14.248-11.835-10.738-13.337-9.929-11.591-9.845-9.206-10.046
Depreciation & Amortization 0.2060.240.2360.220.2220.2170.2220.2330.2520.2690.2780.1140.1070.1190.1720.1060.1010.0990.0880.073
Deferred Income Tax -0.0680.0340.0340.0450.0320.0320.0320.3530.0140.0040.0210.1740.0070.0220.016-0.1310.1560.0010.130.271
Stock Based Compensation 4.1584.424.0283.28214.0834.2333.9382.6872.6862.6512.7442.551.8551.9091.8320.7860.5130.190.2020.145
Change In Working Capital 1.9352.428-4.363-0.345-3.521.3963.761.9040.458-0.216-3.1830.5471.249-0.225-2.996-1.934.7950.7331.4620.242
Accounts Receivables 00000000000000000000
Change In Inventory 00000000000000000000
Change In Accounts Payables -0.140.172-0.814-0.81-2.2122.8471.324-0.4710.864-0.705-0.410.506-0.106-0.8812.2080.030.38-1.311-0.2450.242
Other Working Capital 2.0752.256-3.5490.465-1.308-1.4512.4362.375-0.4060.489-2.7730.0411.3550.656-5.204-1.964.4152.0441.7070.485
Other Non Cash Items -0.741-0.5654.954-1.499-1.749-0.975-0.806-0.566-0.0260.060.6130.1940.5350.153-0.0033.711-0.287-1.4670.037-0.213
Operating Cash Flow -16.455-16.179-22.798-19.316-20.699-12.993-14.382-11.211-13.436-11.162-13.3-10.669-8.082-8.76-14.316-7.387-6.313-8.822-7.287-9.528
Investing Activities:
Investments In Property Plant And Equipment 0-0.013-0.029-0.044-0.00800-0.0340.008-0.007-0.242-0.2-0.074-0.042-0.024-0.047-0.005-0.102-0.43-0.28
Acquisitions Net 000-0.0470.022000.0150.0010.0160000000000
Purchases Of Investments 00-50.594-5.018-64.07-182.831-23.862-48.011-29.249-38.037-24.434-19.721-8.983-40.801-96.792000-0.715-1.66
Sales Maturities Of Investments 31.7542.20458.6252.29441.76591.99451.79333.49928.00122.0734.16413.513.519.94100007.9926.007
Other Investing Activites 008.0260.047-0.022-0.0910.028-0.015-0.001-0.0169.73-6.2214.517-20.86-96.7920007.2774.347
Investing Cash Flow 31.7542.1917.99747.232-22.313-90.83727.931-14.546-1.24-15.9749.488-6.4214.443-20.902-96.816-0.047-0.005-0.1026.8474.067
Financing Activities:
Debt Repayment 0000000000000000016.87600
Common Stock Issued 162.3120.399013.6870.020.48927.924106.10861.1450.1240-136.362133.023133.023136.36269.3770000
Common Stock Repurchased 0000000000000000000-0.001
Dividends Paid 00000000000000000000
Other Financing Activities 0.980.39900.1750.020.489-0.344-0.138-0.1440.12400.0160.797-1.589-1.19368.640.0320-0.033-0.023
Financing Cash Flow 163.2920.399013.8620.020.48927.924106.22761.1450.12400.0160.797-1.589135.16968.640.03216.876-0.033-0.023
Other Information:
Effect Of Forex Changes On Cash 0.053-0.014-0.0260.255-0.034-0.094-0.010.045-0.154-0.061-0.0080.0220.0040.011-0.062-0.1560.452-0.058-0.1580.324
Net Change In Cash 178.6426.397-14.82742.033-43.026-103.43541.11980.25846.171-27.073-3.82-17.052-2.838-31.2423.97561.05-5.8347.894-0.631-5.16
Cash At End Of Period 270.13691.49665.09979.92637.89380.919184.354143.23562.97716.80643.87947.69964.75167.58998.82974.85413.80419.63811.74412.375